Literature DB >> 15647230

Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001.

Samuel H Zuvekas1.   

Abstract

This paper uses detailed data on prescription drug and other services from the Medical Expenditure Panel Survey (MEPS) to examine recent trends in mental health and substance abuse (MH/SA) treatment between 1996 and 2001. While use of ambulatory services remained constant, prescription drug use increased rapidly, with the result that 5.5 million more Americans received treatment in 2001. Prescription drug spending increased at a real rate of almost 20 percent a year. About one-third of this increase came from more MH/SA medication users and two-thirds from higher costs per user.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647230     DOI: 10.1377/hlthaff.24.1.195

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  34 in total

1.  Ten-year trends in quality of care and spending for depression: 1996 through 2005.

Authors:  Catherine A Fullerton; Alisa B Busch; Sharon-Lise T Normand; Thomas G McGuire; Arnold M Epstein
Journal:  Arch Gen Psychiatry       Date:  2011-12

2.  Current Status and Future Prospects of Clinical Psychology: Toward a Scientifically Principled Approach to Mental and Behavioral Health Care.

Authors:  Timothy B Baker; Richard M McFall; Varda Shoham
Journal:  Psychol Sci Public Interest       Date:  2008-11-01

3.  Pharmaceutical cost management and access to psychotropic drugs: the U.S. context.

Authors:  Haiden A Huskamp
Journal:  Int J Law Psychiatry       Date:  2005 Sep-Oct

4.  Prices, profits, and innovation: examining criticisms of new psychotropic drugs' value.

Authors:  Haiden A Huskamp
Journal:  Health Aff (Millwood)       Date:  2006 May-Jun       Impact factor: 6.301

5.  Prevalence and correlates of psychotropic medication use among older adults in Israel: cross-sectional and longitudinal findings from two cohorts a decade apart.

Authors:  Tzvia Blumstein; Yael Benyamini; Angela Chetrit; Eliyahu H Mizrahi; Liat Lerner-Geva
Journal:  Aging Ment Health       Date:  2012       Impact factor: 3.658

6.  Changes in how health plans provide behavioral health services.

Authors:  Constance M Horgan; Deborah W Garnick; Elizabeth Levy Merrick; Dominic Hodgkin
Journal:  J Behav Health Serv Res       Date:  2007-09-14       Impact factor: 1.505

7.  Factors associated with antidepressant, anxiolytic, and other psychotropic medication use to treat psychiatric symptoms in the city of São Paulo, Brazil.

Authors:  Sergio L Blay; Gerda G Fillenbaum; José C Pitta; Erica T Peluso
Journal:  Int Clin Psychopharmacol       Date:  2014-05       Impact factor: 1.659

8.  Off-licence prescribing and regulation in psychiatry: current challenges require a new model of governance.

Authors:  Philip Sugarman; Amy Mitchell; Catherine Frogley; Geoffrey L Dickens; Marco Picchioni
Journal:  Ther Adv Psychopharmacol       Date:  2013-08

9.  Research article: Antidepressant use among Asians in the United States.

Authors:  Hector M González; Wassim Tarraf; Brady T West; Domin Chan; Patricia Y Miranda; Fredrick T Leong
Journal:  Depress Anxiety       Date:  2010       Impact factor: 6.505

10.  Racial and ethnic disparities in the treatment of a Medicaid population with schizophrenia.

Authors:  Marcela Horvitz-Lennon; Thomas G McGuire; Margarita Alegria; Richard G Frank
Journal:  Health Serv Res       Date:  2009-09-24       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.